Jan Münch
7Patents
1h-index
7Co-inventors
40Inventor score
Filing activity: Nov 8, 2000 → Jun 12, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9045563B2 | CXC chemokine receptor 4 (CXCR4) antagonistic polypeptide | Emerging Cross-Sectional Technologies | 2 | Active |
| US8652483B2 | Viral infection enhancing peptide | Chemistry; Metallurgy | 1 | Active |
| US7037896B1 | Peptide (VIRIP) which inhibits a circulating virus in humans and the use thereof | Human Necessities | 0 | Expired |
| US7741287B2 | Peptides for the treatment of herpes virus infections | Human Necessities | 0 | Active |
| US7655629B2 | Peptides and their use for the treatment of HIV infections | Human Necessities | 0 | Expired |
| US10294272B2 | Peptides with antagonistic activities against natural CXCR4 | Emerging Cross-Sectional Technologies | 0 | Active |
| US8299031B2 | Human semen enhancer of viral infection peptides (SEVI) and their use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.